CN111067981A - 一种保健药酒及其制备方法 - Google Patents
一种保健药酒及其制备方法 Download PDFInfo
- Publication number
- CN111067981A CN111067981A CN202010038711.3A CN202010038711A CN111067981A CN 111067981 A CN111067981 A CN 111067981A CN 202010038711 A CN202010038711 A CN 202010038711A CN 111067981 A CN111067981 A CN 111067981A
- Authority
- CN
- China
- Prior art keywords
- parts
- health
- wine
- medicinal liquor
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 25
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 23
- 235000010726 Vigna sinensis Nutrition 0.000 claims abstract description 22
- 239000011435 rock Substances 0.000 claims abstract description 22
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 15
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 15
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 15
- 241000632227 Antenoron Species 0.000 claims abstract description 14
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract description 14
- 240000004980 Rheum officinale Species 0.000 claims abstract description 10
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 10
- 201000005569 Gout Diseases 0.000 claims abstract description 8
- 206010034464 Periarthritis Diseases 0.000 claims abstract description 8
- 241001278833 Rosa laevigata Species 0.000 claims abstract description 8
- 235000000661 Rosa laevigata Nutrition 0.000 claims abstract description 8
- 241000025505 Pyrrosia Species 0.000 claims abstract description 5
- 201000010099 disease Diseases 0.000 claims abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 4
- 241000218628 Ginkgo Species 0.000 claims description 23
- 241000219977 Vigna Species 0.000 claims description 20
- 230000036541 health Effects 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 208000002193 Pain Diseases 0.000 abstract description 9
- 241000219061 Rheum Species 0.000 abstract description 8
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000003467 diminishing effect Effects 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 244000194101 Ginkgo biloba Species 0.000 abstract 2
- 244000042314 Vigna unguiculata Species 0.000 abstract 2
- 239000003814 drug Substances 0.000 description 10
- 230000006870 function Effects 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 240000008168 Ficus benjamina Species 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
- C12G3/05—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
- C12G3/055—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides extracted from plants
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明实施例公开了一种保健药酒及其制备方法,属于保健酒技术领域。所述保健药酒包括以下重量份数的原料:石苇20~30份、石菖蒲25~35份、金樱子5~15份、车前草30~40份、金钱草10~20份、岩豇豆5~10份、银杏果5~10份、风滕1~5份、大黄1~5份、酒1400~1600份。本发明的保健药酒,以石苇、石菖蒲、金樱子、车前草、金钱草、岩豇豆、银杏果、风滕、大黄、酒为原料,诸药合用,起到祛除湿气、活血化瘀、消炎止痛的作用,对于治疗患者的风湿、肩周炎、类风湿、痛风具有很好的疗效,而且其几乎没有副作用,具有广阔的应用前景。
Description
技术领域
本发明实施例涉及保健酒技术领域,具体涉及一种保健药酒及其制备方法。
背景技术
药酒,是指将中药材中有效物质溶解在酒中而制得的一种内服、外用均可的澄清酒类制剂。不仅具有配制方便、药性稳定、安全有效的特点,而且因为酒精是一种良好的半极性有机溶剂,中药的各种有效成分都易溶于其中,药借酒力、酒助药势而充分发挥其效力,提高疗效。
随着经济的高速发展,社会竞争的日趋激烈,人们生活节奏的加快以及饮食结构的改变而导致的健康问题日渐普遍。例如长时间的劳累或软组织损伤、风寒的侵入等容易患上肩周炎、关节炎、风湿痛等,热量摄入增加、高嘌呤食品增加及运动量的减少容易患上痛风等。虽然市面上出现大量具有预防、治疗作用的保健药物,但存在功能单一、疗效不显著的缺陷,严重影响着人们的正常生活和工作。
因此,研发一种多功能保健药酒以解决人们的健康问题有着重要的意义。
发明内容
为此,本发明实施例提供一种保健药酒及其制备方法,以解决现有保健药物存在的功能单一、疗效不显著的缺陷。
为了实现上述目的,本发明实施例提供如下技术方案:
根据本发明实施例的第一方面,本发明实施例提供了一种保健药酒,包括以下重量份数的原料:石苇20~30份、石菖蒲25~35份、金樱子5~15份、车前草30~40份、金钱草10~20份、岩豇豆5~10份、银杏果5~10份、风滕1~5份、大黄1~5份、酒1400~1600份。
进一步地,包括以下重量份数的原料:石苇22~28份、石菖蒲28~32份、金樱子8~12份、车前草32~37份、金钱草13~17份、岩豇豆5~8份、银杏果5~8份、风滕2~4份、大黄2~4份、酒1400~1600份。
进一步地,包括以下重量份数的原料:石苇25份、石菖蒲30份、金樱子10份、车前草35份、金钱草15份、岩豇豆7份、银杏果8份、风滕3份、大黄3份、酒1500份。
进一步地,所述酒的酒精度数为45~50度。
其中,石苇:性微寒,味甘、苦。能有效缓解便血,避免便血对身体的影响。清肺化痰:能缓解上火引发的咳嗽。抗菌消炎:它对部分细菌有很好的抑制作用。利水通淋:它可以入肺经还能入膀胱经,可以起到利水通淋的功效。
石菖蒲:辛、苦,温。归心、胃经。功能主治化湿开胃,开窍豁痰,醒神益智。用于脘痞不饥,噤口下痢,神昏癫痫,健忘耳聋。
金樱子:性平,味酸、甘、涩。归肾经、膀胱经、大肠经。固精、缩尿、涩肠、止泻。属收涩药下分类的固精缩尿止带药。用治遗精、滑精、遗尿、尿频、带下、久泻、久痢等。
车前草:味甘,性寒。归肝、肾、膀胱经。功效:清热,利尿,祛痰,凉血,解毒。用于水肿尿少,热淋涩痛,暑湿泻痢,痰热咳嗽,吐血衄血,痈肿疮毒。
金钱草:甘、咸,微寒。归肝、胆、肾、膀胱经。功能主治清利湿热,通淋,消肿。用于热淋,沙淋,尿涩作痛,黄疸尿赤,痈肿疔疮,毒蛇咬伤;肝胆结石,尿路结石。
岩豇豆:味辛、微甘,性平。归肺、脾经。散风止咳,化食消积。主治:风寒咳嗽,小儿疳积,外伤出血。
银杏果:敛肺气,定喘嗽,止带浊,缩小便。主治哮喘,痰嗽,白带,白浊,遗精,淋病,小便频数。作用包括:1、延缓衰老。由于银杏果含有丰富的维生素C、核黄素、胡萝卜素等,因此可以抗氧化,保护细胞的完整性,延缓衰老。2、预防心脑血管疾病。含有抗血小板活化因子,可以防止血液的凝集,改善血液循环,防止血栓的形成,黄酮则能扩张血管,消除自由基,防止动脉硬化,防止心肌梗塞等,并提高人体免疫力。3、消灭杀菌。银杏果具有抗过敏作用,消炎杀菌功能,抗肿瘤作用,对生殖系统,消化系统,泌尿系统等都有一定的作用。
风滕:为桑科植物爬藤榕的根、茎。味辛、苦,性微温。入肝、脾、肾经。功能主治:治风湿。
大黄:味苦,性寒。归脾、胃、大肠、肝、心包经。功能主治泻热通肠,凉血解毒,逐瘀通经。用于实热便秘,积滞腹痛,泻痢不爽,湿热黄疸,血热吐衄,目赤,咽肿,肠痈腹痛,痈肿疔疮,瘀血经闭,跌打损伤,外治水火烫伤;上消化道出血。酒大黄善清上焦血分热毒。用于目赤咽肿,齿龈肿痛。熟大黄泻下力缓,泻火解毒。用于火毒疮疡。大黄炭凉血化瘀止血。用于血热有瘀出血症。
根据本发明实施例的第二方面,本发明实施例提供了一种上述的保健药酒的制备方法,包括以下步骤:
1)按配方备好各原料;
2)将石苇、石菖蒲、金樱子、车前草、金钱草、岩豇豆、银杏果、风滕、大黄分别研磨粉碎,得到药粉,将药粉放入酒中浸泡,过滤,得到所述保健药酒。
进一步地,所述药粉的粒径为80~120目。
进一步地,浸泡时间为15~20天。
根据本发明实施例的第三方面,本发明实施例提供了一种上述的保健药酒在治疗风湿、肩周炎、类风湿、痛风中的应用。
本发明实施例具有如下优点:
本发明的保健药酒,以石苇、石菖蒲、金樱子、车前草、金钱草、岩豇豆、银杏果、风滕、大黄、酒为原料,诸药合用,起到祛除湿气、活血化瘀、消炎止痛的作用,对于治疗患者的风湿、肩周炎、类风湿、痛风具有很好的疗效,而且几乎没有副作用,具有广阔的应用前景。
具体实施方式
以下由特定的具体实施例说明本发明的实施方式,熟悉此技术的人士可由本说明书所揭露的内容轻易地了解本发明的其他优点及功效,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
本实施例的保健药酒包括以下重量份数的原料:石苇28份、石菖蒲25份、金樱子12份、车前草35份、金钱草18份、岩豇豆8份、银杏果5份、风滕3份、大黄3份、酒精度数为45度的酒1550份。
其制备方法包括以下步骤:
1)按配方备好各原料;
2)将石苇、石菖蒲、金樱子、车前草、金钱草、岩豇豆、银杏果、风滕、大黄分别研磨粉碎,得到粒径为100目的药粉,将药粉放入酒中浸泡15天,过滤,得到所述保健药酒。
实施例2
本实施例的保健药酒包括以下重量份数的原料:石苇25份、石菖蒲30份、金樱子10份、车前草35份、金钱草15份、岩豇豆7份、银杏果8份、风滕3份、大黄3份、酒精度数为45度的酒1500份。
其制备方法包括以下步骤:
1)按配方备好各原料;
2)将石苇、石菖蒲、金樱子、车前草、金钱草、岩豇豆、银杏果、风滕、大黄分别研磨粉碎,得到粒径为80目的药粉,将药粉放入酒中浸泡20天,过滤,得到所述保健药酒。
实施例3
本实施例的保健药酒包括以下重量份数的原料:石苇20份、石菖蒲30份、金樱子8份、车前草30份、金钱草20份、岩豇豆5份、银杏果7份、风滕2份、大黄1份、酒精度数为50度的酒1450份。
其制备方法包括以下步骤:
1)按配方备好各原料;
2)将石苇、石菖蒲、金樱子、车前草、金钱草、岩豇豆、银杏果、风滕、大黄分别研磨粉碎,得到粒径为100目的药粉,将药粉放入酒中浸泡18天,过滤,得到所述保健药酒。
实施例4
本实施例的保健药酒包括以下重量份数的原料:石苇30份、石菖蒲28份、金樱子15份、车前草37份、金钱草10份、岩豇豆8份、银杏果6份、风滕5份、大黄4份、酒精度数为48度的酒1400份。
其制备方法包括以下步骤:
1)按配方备好各原料;
2)将石苇、石菖蒲、金樱子、车前草、金钱草、岩豇豆、银杏果、风滕、大黄分别研磨粉碎,得到粒径为100目的药粉,将药粉放入酒中浸泡18天,过滤,得到所述保健药酒。
实施例5
本实施例的保健药酒包括以下重量份数的原料:石苇24份、石菖蒲35份、金樱子5份、车前草40份、金钱草13份、岩豇豆10份、银杏果10份、风滕1份、大黄5份、酒精度数为48度的酒1600份。
其制备方法包括以下步骤:
1)按配方备好各原料;
2)将石苇、石菖蒲、金樱子、车前草、金钱草、岩豇豆、银杏果、风滕、大黄分别研磨粉碎,得到粒径为120目的药粉,将药粉放入酒中浸泡15天,过滤,得到所述保健药酒。
实验例1
为了说明本发明实施例的保健药酒具有治疗风湿、肩周炎、类风湿、痛风的效果,进行了如下实验。
1临床资料
选择自愿参加本次试验的400例患者,其中,风湿、肩周炎、类风湿、痛风患者分别100例,采取随机分组法,将患者分成治疗1-5组,每组各80例。各组患者的一般资料在对比中无统计方面的差异,P>0.05,具有可比性。
对于未达到18岁以及年龄超过60岁的患者、患有原发性疾病的患者、精神状态不佳的患者、以及由于不具备劳动能力和行为能力的患者,不纳入研究范围。
2治疗方法
治疗1-5组:分别使用实施例1-5的保健药酒进行治疗,使用方法:每天擦患处2~3次,并且每天口服20~30ml保健药酒,7天为一疗程,共3个疗程。
3疗效标准
显效:患者自觉局部疼痛消失,局部无压痛,功能运动正常,患部舒适。
有效:患者自觉局部疼痛部分缓解,局部轻度压痛,功能运动部分正常,患部舒适感增加。
无效:患者在用药后,自觉局部疼痛无缓解,局部压痛明显,功能运动不正常,患部舒适感不明显。
4结果
临床结果见表1。
表1
结果表明,本发明实施例的保健药酒能够有效缓解风湿、肩周炎、类风湿、痛风症状,总有效率达到87.5%以上,疗效显著。
安全性评价:对治疗1-5组患者在治疗前后的血尿常规、肝肾功能、心电图等做了检查并记录详情,对比未发现异常,可见本发明实施例的保健药酒安全、无毒副作用。
虽然,上文中已经用一般性说明及具体实施例对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (8)
1.一种保健药酒,其特征在于,包括以下重量份数的原料:石苇20~30份、石菖蒲25~35份、金樱子5~15份、车前草30~40份、金钱草10~20份、岩豇豆5~10份、银杏果5~10份、风滕1~5份、大黄1~5份、酒1400~1600份。
2.根据权利要求1所述的保健药酒,其特征在于,包括以下重量份数的原料:石苇22~28份、石菖蒲28~32份、金樱子8~12份、车前草32~37份、金钱草13~17份、岩豇豆5~8份、银杏果5~8份、风滕2~4份、大黄2~4份、酒1400~1600份。
3.根据权利要求1所述的保健药酒,其特征在于,包括以下重量份数的原料:石苇25份、石菖蒲30份、金樱子10份、车前草35份、金钱草15份、岩豇豆7份、银杏果8份、风滕3份、大黄3份、酒1500份。
4.根据权利要求1所述的保健药酒,其特征在于,所述酒的酒精度数为45~50度。
5.一种权利要求1~4任一所述的保健药酒的制备方法,其特征在于,包括以下步骤:
1)按配方备好各原料;
2)将石苇、石菖蒲、金樱子、车前草、金钱草、岩豇豆、银杏果、风滕、大黄分别研磨粉碎,得到药粉,将药粉放入酒中浸泡,过滤,得到所述保健药酒。
6.根据权利要求5所述的保健药酒的制备方法,其特征在于,所述药粉的粒径为80~120目。
7.根据权利要求5所述的保健药酒的制备方法,其特征在于,浸泡时间为15~20天。
8.权利要求1所述的保健药酒在治疗风湿、肩周炎、类风湿、痛风中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010038711.3A CN111067981A (zh) | 2020-01-14 | 2020-01-14 | 一种保健药酒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010038711.3A CN111067981A (zh) | 2020-01-14 | 2020-01-14 | 一种保健药酒及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111067981A true CN111067981A (zh) | 2020-04-28 |
Family
ID=70323394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010038711.3A Pending CN111067981A (zh) | 2020-01-14 | 2020-01-14 | 一种保健药酒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111067981A (zh) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1337239A (zh) * | 2000-08-08 | 2002-02-27 | 苗凤菊 | 追风祛痛膏 |
CN1454652A (zh) * | 2003-01-07 | 2003-11-12 | 刘树生 | 一种治疗跌打损伤、风湿痛等病的药酒及其制备方法 |
CN104887829A (zh) * | 2015-05-29 | 2015-09-09 | 张健 | 一种治疗痛风的中药 |
CN104940449A (zh) * | 2014-03-27 | 2015-09-30 | 罗彩莲 | 治疗痛风的药物 |
CN107137629A (zh) * | 2016-03-01 | 2017-09-08 | 李振达 | 一种治疗痛风性关节炎方 |
CN107898979A (zh) * | 2018-01-14 | 2018-04-13 | 戴建华 | 一种治疗温热蕴结型胁痛的中药及其制备方法 |
CN108096497A (zh) * | 2018-01-20 | 2018-06-01 | 成都风靡生物科技有限公司 | 一种用于治疗痛风的丸剂药物及其制备方法 |
CN109718306A (zh) * | 2017-10-31 | 2019-05-07 | 四川省广安观阁职业中学校 | 一种药酒 |
CN110624075A (zh) * | 2018-06-22 | 2019-12-31 | 黄玉梅 | 一种中药药酒的配方 |
-
2020
- 2020-01-14 CN CN202010038711.3A patent/CN111067981A/zh active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1337239A (zh) * | 2000-08-08 | 2002-02-27 | 苗凤菊 | 追风祛痛膏 |
CN1454652A (zh) * | 2003-01-07 | 2003-11-12 | 刘树生 | 一种治疗跌打损伤、风湿痛等病的药酒及其制备方法 |
CN104940449A (zh) * | 2014-03-27 | 2015-09-30 | 罗彩莲 | 治疗痛风的药物 |
CN104887829A (zh) * | 2015-05-29 | 2015-09-09 | 张健 | 一种治疗痛风的中药 |
CN107137629A (zh) * | 2016-03-01 | 2017-09-08 | 李振达 | 一种治疗痛风性关节炎方 |
CN109718306A (zh) * | 2017-10-31 | 2019-05-07 | 四川省广安观阁职业中学校 | 一种药酒 |
CN107898979A (zh) * | 2018-01-14 | 2018-04-13 | 戴建华 | 一种治疗温热蕴结型胁痛的中药及其制备方法 |
CN108096497A (zh) * | 2018-01-20 | 2018-06-01 | 成都风靡生物科技有限公司 | 一种用于治疗痛风的丸剂药物及其制备方法 |
CN110624075A (zh) * | 2018-06-22 | 2019-12-31 | 黄玉梅 | 一种中药药酒的配方 |
Non-Patent Citations (3)
Title |
---|
张英帅,等: "舒筋风湿酒质量标准的含量检测指标研究", 《海峡药学》 * |
胡莹,等: "中药对原发性急性痛风性关节炎疼痛的疗效观察", 《实用药物与临床》 * |
蒋维强: "试论痛风从脏腑辨证论治", 《浙江中医杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104667244B (zh) | 一种治疗原发性痛经的足浴组合物 | |
CN104352991A (zh) | 一种治疗痛风的中药制剂及其制备方法 | |
CN104399011A (zh) | 一种用于食管癌疼痛的中药组合物及其制备方法 | |
CN104288701A (zh) | 一种治疗胆囊炎的中药组合物 | |
CN102688384B (zh) | 一种治疗慢性咽炎的中药汤剂 | |
CN111588828A (zh) | 一种治疗新冠病毒和病毒性疾病的中药制剂及制备方法 | |
CN104524481B (zh) | 一种治疗肠易激综合征的中药及其制备方法 | |
CN111067981A (zh) | 一种保健药酒及其制备方法 | |
CN108324920B (zh) | 一种治疗便秘的中药组合物及制备方法 | |
CN105031595A (zh) | 一种治疗钱币状湿疹的中药片剂及其制备方法 | |
CN107184916B (zh) | 一种具有治疗抑郁症功效的中药组合物、制备方法及应用 | |
CN105031596A (zh) | 一种治疗钱币状湿疹的软膏及其制备方法 | |
CN110613812A (zh) | 一种具有消积通便排毒功效的中药组合物及其制备方法 | |
CN104740405B (zh) | 一种治疗过敏性紫癜性肾损害的中药制剂及制备方法 | |
CN109464565A (zh) | 一种治疗胸痹心痛的中药组合物及其制剂 | |
CN108126117A (zh) | 一种治疗脑梗塞的中药组合物 | |
CN107854662A (zh) | 一种治疗肝硬化腹水的中药制剂及其制备方法 | |
CN106729443A (zh) | 一种用于消肿止痛的中药组合物及其制备方法 | |
CN106822734A (zh) | 一种通痹止痛外敷药袋 | |
CN104825883A (zh) | 一种治疗鼻炎的中药方剂 | |
CN105853933A (zh) | 一种用于治疗乳腺癌术后复发转移的中药制剂及制备方法 | |
CN105288158A (zh) | 一种治疗寒湿型慢性鼻炎的中药 | |
CN104758346A (zh) | 一种治疗偏头痛的药物及其制备方法、制剂 | |
CN104491537A (zh) | 一种治疗风湿性心脏病的中药组合物 | |
CN104116991A (zh) | 一种治疗放射病的中药制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200428 |